Asia-Pacific Topotecan Hydrochloride Market by
Manufacturers, Regions, Type and Application,
Forecast to 2022
No of Pages – 124
Publishing Date - June 2, 2017
Browse detailed TOC, Tables, Figures, Charts in Asia-Pacific Topotecan Hydrochloride
Market by Manufacturers, Regions, Type and Application, Forecast to 2022 at -
http://www.360marketupdates.com/10672903
Topotecan Hydrochloride is the hydrochloride salt of a semisynthetic derivative of camptothecin
with antineoplastic activity. During the S phase of the cell cycle, topotecan selectively stabilizes
topoisomerase I-DNA covalent complexes, inhibiting religation of topoisomerase I-mediated single-
strand DNA breaks and producing potentially lethal double-strand DNA breaks when complexes are
encountered by the DNA replication machinery. Camptothecin is a cytotoxic quinoline-based
alkaloid extracted from the Asian tree Camptotheca acuminata.
Scope of the Report:
This report focuses on the Topotecan Hydrochloride in Asia-Pacific market, especially in China,
Japan, Korea, Taiwan, Southeast Asia, India and Australia. This report categorizes the market based
on manufacturers, countries/Regions, type and application.
Market Segment by Manufacturers, this report covers
Ark Pharm
Wilshire Technologies
ChemFaces
Boc Sciences
CAYMAN CHEMICAL
Market Segment by Countries, covering
China
Japan
Korea
Taiwan
Southeast Asia
India
Australia
Market Segment by Type, covers
Purity >98%
Purity ?98%
Market Segment by Applications, can be divided into